Bionano Genomics (BNGO) Short-term Investments (2021 - 2026)

Bionano Genomics has reported Short-term Investments for 6 years, with the latest figure at $10.3 million in Q1 2026.

• Quarterly Short-term Investments fell 29.71% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (down 29.71% YoY) and the FY2025 annual result came in at $10.3 million, down 6.36% from the prior year.
• Short-term Investments steadied at $10.3 million in Q1 2026 per BNGO's latest filing, from $10.3 million in the prior quarter.
• Over five years, Short-term Investments peaked at $192.4 million in Q1 2022 and troughed at $3.2 million in Q3 2024.
• A 5-year average of $52.5 million and a median of $16.6 million in 2025 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments tumbled 89.1% in 2024, then jumped 485.44% in 2025.
• Over 5 years, Short-term Investments stood at $152.0 million in 2022, then slumped by 67.88% to $48.8 million in 2023, then sank by 77.47% to $11.0 million in 2024, then decreased by 6.36% to $10.3 million in 2025, then retreated by 0.33% to $10.3 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $10.3 million, $10.3 million, and $18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.